STOCK TITAN
  1. Home
  2. Sec-filings
  3. CNSP
  4. [8-K] CNS Pharmaceuticals, Inc. Reports Material Event

[8-K] CNS Pharmaceuticals, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock CNSP logo
CNS Pharmaceuticals

NASDAQ:CNSP

CNSP Rankings

#6431 Ranked by Market Cap
N/A Ranked by Dividends

CNSP Latest News

Sep 3, 2025
CNS Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference
Aug 15, 2025
CNS Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Corporate Update
Aug 14, 2025
CNS Pharmaceuticals to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech
Jul 22, 2025
CNS Pharmaceuticals to Participate in the Virtual Investor "What’s Your Story" Summer Spotlight On-Demand Conference
Jul 18, 2025
CNS Pharmaceuticals Announces Reverse Stock Split

CNSP Latest SEC Filings

Aug 14, 2025
[SCHEDULE 13G] CNS Pharmaceuticals, Inc. SEC Filing
Jul 15, 2025
[8-K] CNS Pharmaceuticals, Inc. Reports Material Event

CNSP Stock Data

4.02M
573.61k
0.17%
7.44%
11.06%
Biotechnology
Pharmaceutical Preparations
Link
United States
HOUSTON